FDA Orange Book
Generic for Tigan
Tigan contains trimethobenzamide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Tigan is trimethobenzamide. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP.
Run it in Rivvi
Map Tigan and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Tigan products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | 300MG | Discontinued | None | 2 | AB |
| injectable, injection | 100MG/ML | Marketed (Rx) | AP | 1 | AP |
NDA 017531, 017530, held by KING PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic trimethobenzamide
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| LUPIN INC | 076546 | AB (A-rated, therapeutically equivalent) | August 20, 2003 | 300MG |
| HERITAGE PHARMA LABS INC DBA AVET PHARMACEUTICALS LABS INC | 205950 | AB (A-rated, therapeutically equivalent) | November 21, 2023 | 300MG |
| BPI LABS LLC | 219606 | AP (A-rated, therapeutically equivalent) | October 16, 2025 | 100MG/ML |
Tigan NDC codes
Questions
Is there a generic for Tigan?
Yes. The generic name for Tigan is trimethobenzamide. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP.
What is the generic name for Tigan?
The active ingredient in Tigan is trimethobenzamide, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.